Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Roberts

Showing results (81-90 of 681) with videos related to

Pageof 69
Sort By:
Expert Review of Anti-Infective Therapy|November 17, 2020
Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients - the role of therapeutic drug monitoringSu Ann Ho, Monica Slavin, Jason A Roberts, et al.
Diagnostic Microbiology and Infectious Disease|March 8, 2014
The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?Stijn Blot, Jeffrey Lipman, Darren M Roberts, et al.
International Journal of Antimicrobial Agents|March 4, 2017
Dosing antibiotic prophylaxis during cardiopulmonary bypass-a higher level of complexity? A structured reviewFathima Paruk, Fekade B Sime, Jeffrey Lipman, et al.
Critical Care Medicine|June 19, 2018
The authors replyNathaniel J Rhodes, Jiajun Liu, Jeffrey Lipman, et al.
Clinical Pharmacokinetics|September 15, 2017
Antibiotic Distribution into Cerebrospinal Fluid: Can Dosing Safely Account for Drug and Disease Factors in the Treatment of Ventriculostomy-Associated Infections?Nilesh Kumta, Jason A Roberts, Jeffrey Lipman, et al.
Critical Care Medicine|July 4, 2008
Antibiotic resistance--what's dosing got to do with it?Jason A Roberts, Peter Kruger, David L Paterson, et al.
International Journal of Antimicrobial Agents|September 18, 2013
Ampicillin/sulbactam: its potential use in treating infections in critically ill patientsSyamhanin Adnan, David L Paterson, Jeffrey Lipman, et al.
International Journal of Antimicrobial Agents|March 5, 2019
Multidrug-resistant Acinetobacter baumannii infections: Current evidence on treatment options and the role of pharmacokinetics/pharmacodynamics in dose optimisationSazlyna Mohd Sazlly Lim, Fekade Bruck Sime, Jason A Roberts
Current Opinion in Critical Care|August 16, 2024
Antibiotic dose optimisation in the critically ill: targets, evidence and future strategiesChristopher J Dyer, Jan J De Waele, Jason A Roberts
Clinical Pharmacokinetics|March 17, 2018
Valganciclovir Pharmacokinetics in Patients Receiving Oral Prophylaxis Following Kidney Transplantation and Model-Based Predictions of Optimal Dosing RegimensThomas Tängdén, Pier Giorgio Cojutti, Jason A Roberts, et al.
Pageof 69

Showing results (81-90 of 681) with videos related to

Sort By:
Pageof 69
Expert Review of Anti-Infective Therapy|November 17, 2020
Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients - the role of therapeutic drug monitoringSu Ann Ho, Monica Slavin, Jason A Roberts, et al.
Diagnostic Microbiology and Infectious Disease|March 8, 2014
The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?Stijn Blot, Jeffrey Lipman, Darren M Roberts, et al.
International Journal of Antimicrobial Agents|March 4, 2017
Dosing antibiotic prophylaxis during cardiopulmonary bypass-a higher level of complexity? A structured reviewFathima Paruk, Fekade B Sime, Jeffrey Lipman, et al.
Critical Care Medicine|June 19, 2018
The authors replyNathaniel J Rhodes, Jiajun Liu, Jeffrey Lipman, et al.
Clinical Pharmacokinetics|September 15, 2017
Antibiotic Distribution into Cerebrospinal Fluid: Can Dosing Safely Account for Drug and Disease Factors in the Treatment of Ventriculostomy-Associated Infections?Nilesh Kumta, Jason A Roberts, Jeffrey Lipman, et al.
Critical Care Medicine|July 4, 2008
Antibiotic resistance--what's dosing got to do with it?Jason A Roberts, Peter Kruger, David L Paterson, et al.
International Journal of Antimicrobial Agents|September 18, 2013
Ampicillin/sulbactam: its potential use in treating infections in critically ill patientsSyamhanin Adnan, David L Paterson, Jeffrey Lipman, et al.
International Journal of Antimicrobial Agents|March 5, 2019
Multidrug-resistant Acinetobacter baumannii infections: Current evidence on treatment options and the role of pharmacokinetics/pharmacodynamics in dose optimisationSazlyna Mohd Sazlly Lim, Fekade Bruck Sime, Jason A Roberts
Current Opinion in Critical Care|August 16, 2024
Antibiotic dose optimisation in the critically ill: targets, evidence and future strategiesChristopher J Dyer, Jan J De Waele, Jason A Roberts
Clinical Pharmacokinetics|March 17, 2018
Valganciclovir Pharmacokinetics in Patients Receiving Oral Prophylaxis Following Kidney Transplantation and Model-Based Predictions of Optimal Dosing RegimensThomas Tängdén, Pier Giorgio Cojutti, Jason A Roberts, et al.
Pageof 69